Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium

References

• LoftS, PoulsenHE. Cancer risk and oxidative DNA damage in man. J Mol Med (Berl) 1996;74:297–312.
   PubMed Web of Science ®Google Scholar
• LoftS, Høgh DanielsenP, MikkelsenL, RisomL, ForchhammerL, MøllerP. Biomarkers of oxidative damage to DNA and repair. Biochem Soc Trans 2008;36:1071–1076.
   PubMed Web of Science ®Google Scholar
• ChurgA. Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species. Free Radic Biol Med 2003;34:1230–1235.
   PubMed Web of Science ®Google Scholar
• ErcalN, Gurer-OrhanH, Aykin-BurnsN. Toxic metals and oxidative stress part i: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001;1:529–539.
   PubMedGoogle Scholar
• LimS, WonH, KimY, JangM, JyothiKR, KimY, DandonaP, HaJ, KimSS. Antioxidant enzymes induced by repeated intake of excess energy in the form of high-fat, high-carbohydrate meals are not sufficient to block oxidative stress in healthy lean individuals. Br J Nutr 2011;106:1544–1551.
   PubMed Web of Science ®Google Scholar
• PoeschlG, SeitzHK. Alcohol and cancer. Alcohol Alcohol 2004;39:155–165.
   PubMedGoogle Scholar
• SeitzHK, StickelF. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599–612.
   PubMed Web of Science ®Google Scholar
• CoronadoGD, BeasleyJ, LivaudaisJ. Alcohol consumption and the risk of breast cancer. Salud Publica Mex 2011;53:440–447.
   PubMed Web of Science ®Google Scholar
• BaiRK, LealSM, CovarrubiasD, LiuA, WongLJC. Mitochondrial genetic background modifies breast cancer risk. Cancer Res 2007;67:4687–4694.
   PubMed Web of Science ®Google Scholar
• WangS, WangF, ShiX, DaiJ, PengY, GuoX, WangX, ShenH, HuZ. Association between manganese superoxide dismutase (MnSOD) val-9Ala polymorphism and cancer risk - a meta-analysis. Eur J Cancer 2009;45:2874–2881.
   PubMed Web of Science ®Google Scholar
• CerneJZ, Pohar-PermeM, NovakovicS, Frkovic-GrazioS, StegelV, GersakK. Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer. J Gynecol Oncol 2011;22:110.
   PubMed Web of Science ®Google Scholar
• SenerDE, GönencA, AkinciM, TorunM. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct 2007;25:377–382. PMID: 16447143.
   PubMedGoogle Scholar
• KangDH. Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 2002;13:540–549. PMID: 12473916.
   PubMedGoogle Scholar
• Gupta-EleraG, GarrettAR, RobisonRA, O’NeillKL. The role of oxidative stress in prostate cancer. Eur J Cancer Prev 2012;21:155–162. PMID: 21857523.
   PubMed Web of Science ®Google Scholar
• KhandrikaL, KumarB, KoulS, MaroniP, KoulHK. Oxidative stress in prostate cancer. Cancer Lett 2009;282:125–136.
   PubMed Web of Science ®Google Scholar
• CoxDG, TamimiRM, HunterDJ. Gene x gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study. BMC Cancer 2006;6:217.
   PubMed Web of Science ®Google Scholar
• PezzottiA, KraftP, HankinsonSE, HunterDJ, BuringJ, CoxDG. The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PLoS One 2009;4:e5356.
   Web of Science ®Google Scholar
• Ibarrola-VillavaM, Peña-ChiletM, FernandezLP, AvilesJA, MayorM, Martin-GonzalezM, et al. Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility. Eur J Cancer 2011;47: 2618–2625.
   PubMed Web of Science ®Google Scholar
• PietrasT, SzemrajJ, WitusikA, HołubM, PanekM, WujcikR, GórskiP. The sequence polymorphism of MnSOD gene in subjects with respiratory insufficiency in COPD.Med Sci Monit 2010;16:CR427–CR432.
   PubMed Web of Science ®Google Scholar
• ChenY, PeiJ. Possible risk modifications in the association between MnSOD Ala9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial. Breast Cancer Res Treat 2011; 125:495–504.
   PubMedGoogle Scholar
• EzzikouriS, El FeydiAE, AfifiR, BenazzouzM, HassarM, PineauP, BenjellounS. Poly- morphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a moroccan population. Free Radic Res 2010;44: 208–216.
   PubMed Web of Science ®Google Scholar
• HunterDJ, RiboliE, HaimanCA, AlbanesD, AltshulerD, ChanockSJ, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 2005;5:977–985.
   PubMedGoogle Scholar
• MéplanC, DragstedLO, Ravn-HarenG, TjønnelandA, VogelU, HeskethJ. Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk. PLoS one 2013;8:e73316.
   PubMed Web of Science ®Google Scholar
• GudmundssonJ, SulemP, RafnarT, BergthorssonJT, ManolescuA, GudbjartssonD, et al. Common sequence variants on 2p15 and xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008;40:281–283.
   PubMed Web of Science ®Google Scholar
• YeagerM, OrrN, HayesRB, JacobsKB, KraftP, WacholderS, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007;39: 645–649.
   PubMed Web of Science ®Google Scholar
• HendricksonSJ, LindströmS, EliassenAH, RosnerBA, ChenC, BarrdahlM, et al. Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2013;22: 927–936. PMID: 23515144.
   PubMedGoogle Scholar
• SteinbrecherA, MéplanC, HeskethJ, SchomburgL, EndermannT, JansenE, et al. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of european men. Cancer Epidemiol Biomarkers Prev 2010;19:2958–2968. PMID: 20852007.
   PubMed Web of Science ®Google Scholar
• ErdemO, EkenA, AkayC, Arsova-SarafinovskaZ, MatevskaN, SuturkovaL, et al. Association of GPX1 polymorphism, GPX activity and prostate cancer risk. Hum Exp Toxicol 2012;31:24–31. PMID: 21636625.
   PubMedGoogle Scholar
• ChengTYD, BarnettMJ, KristalAR, AmbrosoneCB, KingIB, ThornquistMD, et al. Genetic variation in myeloperoxidase modifies the association of serum á- tocopherol with aggressive prostate cancer among current smokers. J Nutr 2011;141:1731–1737. PMID: 21795425.
   PubMed Web of Science ®Google Scholar
• Arsova-SarafinovskaZ, MatevskaN, EkenA, PetrovskiD, BanevS, DzikovaS, et al. Glutathione peroxidase 1 (GPX1) ge- netic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int Urol Nephrol 2009;41:63–70. PMID: 18563616.
   PubMed Web of Science ®Google Scholar
• KucukgerginC, GokpinarM, SanliO, TefikT, OktarT, SeckinS. Association between genetic variants in glutathione peroxidase 1 (GPx1) gene, GPx activity and the risk of prostate cancer. Minerva Urol Nefrol 2011;63:183–190. PMID: 21993316.
   PubMedGoogle Scholar
• ChoiJY, NeuhouserML, BarnettM, HudsonM, KristalAR, ThornquistM, et al. Polymorphisms in oxidative Stress– Related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev 2007; 16:1115–1120.
   PubMedGoogle Scholar
• MenT, ZhangX, YangJ, ShenB, LiX, ChenD, WangJ. The rs1050450 C > T polymorphism of GPX1 is associated with the risk of bladder but not prostate cancer: evidence from a meta-analysis. Tumor Biol 2013; PMID: 23975365.
   Google Scholar